HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.

Bello-Manga H, Abdullahi SU, Hassab H, Brown B, Nduba V, Githanga J, Akinsete AM, El-Beshlawy A, Hanna D, Segbefia C, Okpala I, Tantawy A, Ogutu B, Tubman VN, Paintsil V, Wali Y, Essa M, Telfer P, Dixon S, Hickman A, Doss JF, Davis MW, Rupon J, Kirkham FJ, Brown RC, HOPE Kids 2 Investigators.

Open source

DOI: 10.1002/ajh.70457
Published: 2026-08-28
Container: Am J Hematol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70457,
  title = {HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.},
  author = {Bello-Manga H and  Abdullahi SU and  Hassab H and  Brown B and  Nduba V and  Githanga J and  Akinsete AM and  El-Beshlawy A and  Hanna D and  Segbefia C and  Okpala I and  Tantawy A and  Ogutu B and  Tubman VN and  Paintsil V and  Wali Y and  Essa M and  Telfer P and  Dixon S and  Hickman A and  Doss JF and  Davis MW and  Rupon J and  Kirkham FJ and  Brown RC and  HOPE Kids 2 Investigators.},
  year = {2026},
  journal = {Am J Hematol},
  doi = {10.1002/ajh.70457},
  url = {https://doi.org/10.1002/ajh.70457}
}

RIS

TY  - JOUR
TI  - HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.
AU  - Bello-Manga H
AU  -  Abdullahi SU
AU  -  Hassab H
AU  -  Brown B
AU  -  Nduba V
AU  -  Githanga J
AU  -  Akinsete AM
AU  -  El-Beshlawy A
AU  -  Hanna D
AU  -  Segbefia C
AU  -  Okpala I
AU  -  Tantawy A
AU  -  Ogutu B
AU  -  Tubman VN
AU  -  Paintsil V
AU  -  Wali Y
AU  -  Essa M
AU  -  Telfer P
AU  -  Dixon S
AU  -  Hickman A
AU  -  Doss JF
AU  -  Davis MW
AU  -  Rupon J
AU  -  Kirkham FJ
AU  -  Brown RC
AU  -  HOPE Kids 2 Investigators.
PY  - 2026
JO  - Am J Hematol
DO  - 10.1002/ajh.70457
UR  - https://doi.org/10.1002/ajh.70457
ER  -

APA

H, B., SU, A., H, H., B, B., V, N., J, G., AM, A., A, E., D, H., C, S., I, O., A, T., B, O., VN, T., V, P., Y, W., M, E., P, T., S, D., A, H., JF, D., MW, D., J, R., FJ, K., RC, B., & Investigators., H. K. 2. (2026). HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.. Am J Hematol. https://doi.org/10.1002/ajh.70457

Source records

europe-pmc · retrieved 2026-09-25T02:07:11.679Z